Let's talk medical research

Rare Disease Day occurs every year on the last day of February, and is aimed at raising awareness and creating change for the 300 million individuals across the globe living with a rare disease. In the United States, a rare disease is defined as a condition that impacts less than 200,000 people — by that definition, about 1 in 10 individuals (roughly 30 million people) in America have a rare ...

When sponsors advertise a clinical trial online, they will typically either provide sites with individual advertising budgets or work with a clinical trial recruitment company to create outreach materials. Once created, these materials will undergo the IRB approval process and then be distributed across online channels such as Facebook and Google Ads.

Lupus is a chronic autoimmune disease that causes the body to attack its own tissues and organs. For the 1.5 million people in the United States that live with the disease, it has severe implications — symptoms include pain, fatigue, hair loss, cognitive issues, physical impairments, and disfiguring rashes. An estimated 10-15% of lupus patients will die prematurely due to the condition.

Clinical trial patient recruitment is a major challenge in the industry — 85% of trials fail to recruit enough patients, 80% are delayed due to recruitment problems, and dropout rates soar. Both at the recruitment and retention stages, taking a patient-centric approach to clinical trial design is a must in order to set your trial up for success.

Osteoarthritis (OA) is the most common type of arthritis that impacts the knee joint. It is a result of the knee cartilage progressively wearing away, which can lead to difficulty moving, stiffness, and weakness, all of which worsen with time. Knee OA makes up 80% of diagnosed osteoarthritis cases, impacting 19% of adults over the age of 45.

Increasing diversity, equity, and inclusion (DEI) in clinical trials is a topic that has received a lot of attention in recent years, especially on the heels of the most recent guidance from the Food and Drug Administration — but it is still an area ripe for improvement.

Oftentimes, clinical trial enrollment statistics paint a grim picture of the medical research landscape. A frequently-cited statistic is that approximately 80% of clinical trials are delayed or closed because of problems with recruitment, and there are other troubling statistics such as:

Antidote is dedicated to accelerating medical research by bringing sponsors and patients together. Through our clinical trial matching software, strategic partner relationships, extensive database, and patient-centric focus, we’re transforming the way that patients connect with research — and continually measuring our progress so we can refine the process.

Though clinical trials as we know them have only existed since the 1980s, the past 40 years have been ripe with innovations in the process. From an increased focus on the patient experience to the rise of clinical trial matching software, the world of medical research continues to grow and evolve.

At Antidote, we consider the patient voice in how we think about the entire clinical trial process. From recruitment to randomization, the patient journey is a driving force in all that we do — and we think this strategy is helpful for clinical trial sponsors, as well. Designing treatments, clinical trials, and health solutions around patients practicing patient centricity, and it can have key ...